drug
TEV-408
Phase 2updated 5mo agoby $TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Teva claims success in celiac study; BioMarin, Ascendis settle patent disputeTeva believes the therapy has “pipeline-in-a-product” potential. Elsewhere, a high-stakes trial was paused and GSK advanced a competitor to Moderna’s flu shot.biopharma_dive · 1mo ago
Data sources
last refreshed 24m ago
Found something off?
comments(0)
5-min edit window · permanent after that